Resources | InsightRX Communications

Products
- For Providers
- For Life Sciences
Platform
Company
Resources
Press
- Media InsightRX in the news — digital, print, podcasts, and other outlets
- Press Releases Announcements for events, partnerships, and company updates

KLAS-emerging-company-spotlight

FEATURED POST

InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution

Search Blog section Author Tags

Thought Leadership

Jan 12, 2024

Improving Hospital Workflows by Integrating a Precision Dosing Platform with EHRs

Thought Leadership

Aug 15, 2023

Simulation Demonstrates Potential Effectiveness of Model-Informed Precision Dosing for Heparin

Thought Leadership

Feb 28, 2023

What Does 2023 Hold for Biopharma? Part 5: Technological Advances

Thought Leadership

Jan 3, 2023

The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

Thought Leadership

Dec 16, 2022

What to Expect from AI-Enabled Drug Discovery in 2023

Thought Leadership

Jul 18, 2022

Understanding Project Optimus

Thought Leadership

Apr 6, 2022

Understanding FDA’s Perspective On Precision Dosing

Thought Leadership

Jul 18, 2018

The Right Dose: How Pharmacy Researchers Are Making Medicine More Precise

Thought Leadership

Mar 31, 2018

Investing In The Future Of Healthcare With OSF Healthcare

Maximize therapeutic success with precision medicine.

What We Do

For Providers

Bayesian Dosing (MIPD)
Real-Time Dosing Analytics
Available Drug Modules

For Life Sciences

Precision Dosing in Clinical Trials
PKPD Analytics in Clinical Trials
Companion Applications

How We Do It

Continuous Learning
Integrations
Security & Regulatory
Success & Support
Data Science

Information

Resources

Product Innnovation
Scientific Publications
Thought Leadership
White Papers
How to Cite InsightRX

Press

Media
Press Releases

About

Contact Us
Customers
Leadership
Advisory Board
Mission & Vision
Careers

548 Market Street
#88083
San Francisco, CA 94104

Copyright © InsightRX, Inc.
740-05000-REC-01 08/2025

View our privacy policy

InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance

548 Market Street
#88083
San Francisco, CA 94104